bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer

Histopathology

Volumn 31, Issue 5, 1997, Pages 430-435

  Parenti, A R ^a   Rugge, M ^a   Shiao, Y Horng ^b   Ruol, A ^a   Ancona, E ^a   Bozzola, L ^c   Ninfo, V ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Dipartimento Materno Pediatrico   (Italy)

Author keywords

Apoptosis; Bcl 2; Multistep carcinogenesis; Oesophageal cancer; Oesophageal carcinogenesis; P53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; EARLY CANCER; ESOPHAGUS CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0030659448     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1997.2970888.x     Document Type: Article

References (33)

1. Tomatis L, Aitio A, Day NE et al. Cancer: cause, occurrence and control. IARC Sci. Publ. 1990: 100: 296-298.
2. Sugimachi K, Sumiyoshi K, Nozoe T et al. Carcinogenesis and histogenesis of oesophageal carcinoma. Cancer 1995: 75: 1440-1445.
3. Le Brun DP, Warkne RA, Cleary MI. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol. 1993: 142: 743-753.
4. Bosman FT, Visser BC, van Oeveren J. Apoptosis: pathophysiology of programmed cell death. Path. Res. Pract. 1996: 192: 676-683.
5. Lu QL, Abel P, Foster CS, Lalani EN. bcl-2 role in epithelial differentiation and oncogenesis. Hum. Pathol. 1996: 27: 102-110.
6. Pezzella F, Turley H, Kuzu I et al. bcl-2 protein in non-small-cell lung carcinoma. N Engl. J. Med. 1995: 329: 690-694.
7. Pilotti S, Collini P, Rilke F, Cattoretti G, Del Bo R, Pierotti MA. bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J. Pathol. 1994: 172: 337-342.
8. Colombel M, Symmans F, Gil S et al. Detection of the apoptosis suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 1993: 145: 390-400.
9. Ofner D, Reihemann K, Maier H et al. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumor stage and patient survival. Br. J. Cancer 1995: 72: 981-985.
10. Hurlimann J, Larrinaga B, Vala DC. bcl-2 protein in invasive ductal breast carcinoma. Virchows Arch. 1995: 426: 165-168.
11. Lipponen PK, Aaltomaa S, Eskelinen M, Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours. Histopathology 1996: 28: 135-140.
12. Mosnier JF, Gentil-Perret A, Vindimian M et al. An immunohis- tochemical study ol'the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum. Arch. Pathol. Lab. Med. 1996: 120: 654-659.
13. Nakamura S, Akazawa K, Kinukawa N, Yao T, Tsuneyoshi M. Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum. Pathol. 1996: 27: 225-233.
14. Joensuu H, Pylkkanen L, Toikkanen S. bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol. 1994: 145: 1191-1198.
15. Sarbia M, Bittinger F, Porschen R et al. bcl-2 expression in squamous cell carcinomas of the esophagus. Path. Res. Pract. 1996: 192: 340.
16. Smith LM, Fornace AJ Jr. Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis. Mut. Res. 1996: 340: 109-124.
17. Greenblalt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994: 54: 4855-4878.
18. Rugge M, Bovo D, Busatto G et al. p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous oesophageal cancer in Italy. Cacer Epidemiol. Biomarkers Prev. 1997: 6: 171-176.
19. Parenti AR, Rugge M, Frizzera E et al. p53 overexpression in the multistep process of oesophageal carcinogenesis. Am. J. Surg. Pathol. 1995: 19: 1418-1422.
20. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res. 1995: 55: 237-241.
21. Uesugi H, Saegusa M, Takano Y, Okayasu I, Different expression of bcl-2 protein in gastric adenomas and carcinomas. Pathol. Int. 1996: 46: 274-280.
22. Watanabe H, Jass JR, Sobin LH. Histological Typing of Ooesophageal and Gastric Tumours. 2nd ed. Berlin: Springer Verlag. 1990.
23. Ambros RA, Kurman RJ, Current concepts in the relationship of human papillomavirus infection to the pathogenesis and classification of precancerous squamous lesions of the uterine cervix. Sem. Diagn. Pathol. 1990: 7: 158-172.
24. Beahrs OH, Henson D, Hutter RV, Myers MH eds. American Joint Committee on Cancer. Philadelphia: Lippincott. 1988: 63-65.
25. Spearman C. The proof and measurement of association between two things. Am. J. Psychol. 1904: 15: 72-101.
26. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J. Am. Statist. Assoc. 1958: 53: 457-481.
27. Cox DR. Regression models and life tables. J. Roy. Statist. Sci. 1972: 34: 187-220.
28. Boise LH, Gottschalk AR, Quintans J, Thompson CB. Bcl-2 and bcl-2 related proteins in apoptosis regulation. Curr: Topic. Microbiol. Immunol. 1995: 200: 107-121.
29. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995: 267: 1456-1462.
30. Watson AJM, Merritt AJ, Jones LS et al. Evidence for reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas. Br. J. Cancer 1996: 73: 889-895.
31. Matlashewski G, Banks L, Pim D, Crawford L. Analysis of human p53 protein and mRNA levels in normal and tranformed cells. Eur. J. Biochem. 1986: 154: 665-672.
32. Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 1994: 54: 3131-5135.
33. Haldar S, Negrini M, Monne M, Sabbioni S, Croce CM. Down regulation of bcl-2 and p53 in breast cancer cells. Cancer Res. 1994: 54: 2095-2097.